Synthetic cannabinoid-induced delirium
Delirium induzido por canabinoides sintéticos
CategoryDefinition
Synthetic cannabinoid-induced delirium is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or withdrawal or during the use of synthetic cannabinoids. The amount and duration of synthetic cannabinoid use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders.
Diagnostic Criteria
Essential (Required) Features:
- All diagnostic requirements for 6D70 Delirium are met.
- There is evidence from history, physical examination, or laboratory findings that the neurocognitive disturbance is caused by the direct physiological consequences of use of synthetic cannabinoids. This judgment depends on establishing that the course of the Delirium (e.g., onset, trajectory of symptoms, eventual remission with elimination of the substance from the body) is consistent with causation by use of synthetic cannabinoids.
- The duration or severity of the symptoms is substantially in excess of the characteristic syndrome of Synthetic Cannabinoid Intoxication or Synthetic Cannabinoid Withdrawal.
- The diagnostic requirements for 6D70.2 Delirium Due to Multiple Etiological Factors are not met.
Note: See 6D70 Delirium for other CDDR sections, including Additional Clinical Features, Boundary with Normality (Threshold), Course Features, Developmental Presentations, Culture-Related Features, and Boundaries with Other Disorders and Conditions (Differential Diagnosis).